Biotechnological pharmaceuticals

Weinstein K, Kardos P, Strab R, Hidalgo U (2004) Cultured epithelial cell assays used to estimate intestinal absorption potential. In Borchardt RT, Kerns EH, Lipinski CA, Thakker DR, Wang B (Eds) Biotechnology Pharmaceutical Aspects Vol I Pharmaceutical Profiling in Drug Discovery for Lead Selection. AAPS Press, Arlington, pp 197-216. 

Griebenow, K. and Barletta, G., Dehydrated protein powders as hiocatalysts in nonaqueous solvents. In Lyophilization of Biopharmaceuticals (Biotechnology Pharmaceutical Aspects), Costantino, H.R. and Pikal, M.J. (eds). AAPS Press Arhngton, VA, 2004, pp. 643-668. 

Bruno, J. Application of biosensor assays for the characterization of biopharmaceuticals. 4th Symposium on the Analysis of Well Characterized Biotechnology Pharmaceuticals. San Francisco, Jan. 9-12, 2000. 

Characterization of biotechnology pharmaceutical products, FDA Workshop Proceedings, Washington DC, 1995. 

The early membranologists have always been optimistic about the possibilities of membrane operations, but the scientific and technical results reached today are even superior to the expectation. A variety of technical challenges must be overcome to permit the successful industrial apphcation of new membrane solutions. Chapter 43, on the same theme, presents the future scenario of membrane processes covering chemical, biotechnological, pharmaceutical applications, etc., and also focusing fumre progresses in membrane engineering. 

Survey. Medicines in Development. Biotechnology, Pharmaceutical Research and Manufacturers Association Washington, DC, Oct 2004. 

Shen, W. The versatility of 1,1-dibromo-1-alkenes in palladium-catalyzed coupling reactions. Frontiers of Biotechnology Pharmaceuticals 2000, 1, 349-372. 

Crews, P. Hunter, L.M. In Marine Biotechnology Pharmaceutical and Bioactive Natural Products Attaway, D.H. Zaborsky, O.R., Eds. Plenum Publishing Corporation New York, 1993 pp. 343-349. 

The recent analytical literature abounds with reports on the development of electrochemical, fiber optic, piezoelectric, and other sensors. Novel detection principles are frequently announced, and attainment of improved sensor quality in terms of selectivity, sensitivity, and lifetime are the goal of many established as well as newly formed research groups. The need for continuous monitoring of critical parameters in clinical chemistry, biotechnology, pharmaceutical, chemical, and nuclear industries, chemical warfare or environmental control is the driving force behind the sensor research. 

Organizationally, this monograph is addressed to scientists, technicians and managers of biotechnology, pharmaceutical and chemical companies, research institutes, and biotech ventures, and decision makers in industry, science, venture capital/finance and politics. 

Zoon K, Garnick R (1998). Definition of a well-characterized biotechnology product. In F Brown, A Lubiniecki, G Murano (eds.). Characterization of Biotechnology Pharmaceutical Products, Vol. 96, Dev. Biol. Stand. Karger, Basel Switzerland, pp. 191-197. 

---